HIV Citation List: February 27 - March 12, 2015

PubMed Citations

1. Isolation of a Ribonuclease with Antiproliferative and HIV-1 Reverse Transcriptase Inhibitory Activities from Japanese Large Brown Buckwheat Seeds. Yuan, S., J. Yan, X. Ye, Z. Wu, and T. Ng. Applied Biochemistry and Biotechnology, 2015. 175(5): p. 2456-2467. PMID[25503363].
[PubMed]. HIV_0227-031215.

2. Molecular Modeling, Synthesis and Biological Evaluation of N-Heteroaryl Compounds as Reverse Transcriptase Inhibitors against HIV-1. Singh, A., D. Yadav, M. Yadav, A. Dhamanage, S. Kulkarni, and R.K. Singh. Chemical Biology & Drug Design, 2015. 85(3): p. 336-347. PMID[25055732].
[PubMed]. HIV_0227-031215.

3. Synthesis, Biological Evaluation and Molecular Docking of Calix[4]arene-based beta-Diketo Derivatives as HIV-1 Integrase Inhibitors. Luo, Z., Y. Zhao, C. Ma, Z. Li, X. Xu, L. Hu, N. Huang, and H. He. Archiv der Pharmazie, 2015. 348(3): p. 206-213. PMID[25682937].
[PubMed]. HIV_0227-031215.

4. Azasugar-containing Phosphorothioate Oligonucleotide (Azpson) DBM-2198 Inhibits Human Immunodeficiency Virus Type 1 (HIV-1) Replication by Blocking HIV-1 gp120 without Affecting the V3 Region. Lee, J., S.E. Byeon, J.Y. Jung, M.H. Kang, Y.J. Park, K.E. Jung, and Y.S. Bae. Molecules and Cells, 2015. 38(2): p. 122-129. PMID[25623024].
[PubMed]. HIV_0227-031215.

5. The First Synthesis of 4'-Branched 5'-Deoxycarbocyclic 9-deazaadenosine and Phosphonic acids as Antiviral Agents. Kim, S., E. Kim, and J.H. Hong. Nucleosides, Nucleotides &Nucleic Acids, 2015. 34(3): p. 163-179. PMID[25710354].
[PubMed]. HIV_0227-031215.

6. Design and Synthesis of alpha-Carboxy Nucleoside Phosphonate Analogues and Evaluation as HIV-1 Reverse Transcriptase-targeting Agents. Keane, S.J., A. Ford, N.D. Mullins, N.M. Maguire, T. Legigan, J. Balzarini, and A.R. Maguire. Journal of Organic Chemistry, 2015. 80(5): p. 2479-2493. PMID[25532055].
[PubMed]. HIV_0227-031215.

7. Design, Synthesis, and Biological Evaluation of Novel 2-Methylpiperazine Derivatives as Potent CCR5 Antagonists. Hu, S., Z. Wang, T. Hou, X. Ma, J. Li, T. Liu, X. Xie, and Y. Hu. Bioorganic & Medicinal Chemistry, 2015. 23(5): p. 1157-1168. PMID[25638498].
[PubMed]. HIV_0227-031215.

ISI Web of Knowledge Citations

8. Endogenous CCL2 Neutralization Restricts HIV-1 Replication in Primary Human Macrophages by Inhibiting Viral DNA Accumulation. Sabbatucci, M. Covino, D.A. Purificato, C. Mallano, A. Federioc, M. Lu, J. Rinaldi, A.O. Pellegrini, M. Bona, R. Michelini, Z. Cara, A. Vella, S. Gessani, S. Andreotti, M. Fantuzzi. Retrovirology, 2015. 12(4): 22pp. ISI[000349353400002].
[WOS]. HIV_0227-031215.

9. Aspartic Protease Inhibitors Containing Tertiary Alcohol Transition-state Mimics. Motwani, H.V. De Rosa, M. Odell, L.R. Hallberg, A. Larhed. European Journal of Medicinal Chemistry, 2015. 90: p. 462-490. ISI[000348951900038].
[WOS]. HIV_0227-031215.

10. Design, Synthesis and Biological Activity of Aromatic Diketone Derivatives as HIV-1 Integrase Inhibitors. Hu, L.M., Z.P. Li, Z.Y. Wang, G.X. Liu, X.Z. He, X.L. Wang, and C.C. Zeng. Medicinal Chemistry, 2015. 11(2): p. 180-187. ISI[000349331700009].
[WOS]. HIV_0227-031215.

Patent Citations

11. Preparation of Polycyclic Carbamoylpyridone Derivatives Useful in the Treatment of HIV Infection. Ji, M., S.E. Lazerwith, and H.-J. Pyun. Patent. 2015. 2014-US46413 2015006731: 103pp.

[Patent]. HIV_0227-031215.

12. Preparation of Polycyclic Carbamoylpyridone Derivatives Useful for the Treatment of HIV Infection. Ji, M., T.A.T. Martin, M.C. Desai, H. Jin, and H.-J. Pyun. Patent. 2015. 2014-US46415

2015006733: 96pp.

[Patent]. HIV_0227-031215.

13. Compositions and Methods for Modulating HIV Activation. Karn, J. and B. Das. Patent. 2015. 2014-US48596 2015017399: 52pp.

[Patent]. HIV_0227-031215.

14. Transitmycin Effectiveness against Bacterial and Viral Pathogens. Kumar, V., M. Doble, B. Ramasamy, S. Ganesan, R. Manikkam, L.E. Hanna, S. Swaminathan, and S. Nagamiah. Patent. 2015. 2014-IN20 2015022698: 68pp.

[Patent]. HIV_0227-031215.

15. Inhibitors of Viral Replication, Their Process of Preparation and Their Therapeutical Uses. Ledoussal, B., F. Le Strat, S. Chasset, J. Barbion, J. Brias, A. Caravano, F. Faivre, and S. Vomscheid. Patent. 2015. 2014-EP64446 2015001125: 202pp.

[Patent]. HIV_0227-031215.

16. Medicament Comprising a Pharmaceutical Combination of Dolutegravir, Emtricitabine and Tenofovir for Treatment of Viral Infections. Renner, J. Patent. 2015. 2014-EP67305 2015022351: 31pp.

[Patent]. HIV_0227-031215.

17. Preparation of Piperazine Derivatives as HIV Protease Inhibitors. Williams, P.D., J.A. McCauley, D.J. Bennett, C.J. Bungard, L. Chang, X.-J. Chu, M.P. Dwyer, M.K. Holloway, K.M. Keertikar, H.M. Loughran, J.J. Manikowski, G.J. Morriello, D.-M. Shen, E.C. Sherer, J. Schulz, S.T. Waddell, C.M. Wiscount, N. Zorn, T. Satyanarayana, S. Vijayasaradhi, B. Hu, T. Ji, and B. Zhong. Patent. 2015. 2014-US48581 2015017393: 326pp.

[Patent]. HIV_0227-031215.

18. Preparation of Piperazine Derivatives as HIV Protease Inhibitors. Williams, P.D., J.A. McCauley, D.J. Bennett, C.J. Bungard, L. Chang, X.-J. Chu, M.P. Dwyer, M.K. Holloway, K.M. Keertikar, H.M. Loughran, J.J. Manikowski, G.J. Morriello, D.-M. Shen, E.C. Sherer, J. Schulz, S.T. Waddell, C.M. Wiscount, N. Zorn, S. Tummanapalli, V. Sivalenka, B. Hu, T. Ji, and B. Zhong. Patent. 2015. 2013-CN899 2015013835: 340pp.

[Patent]. HIV_0227-031215.